Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)

NCT03362632 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT03362632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03362632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2018
Completion date
June 30, 2019
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage liver disease, infection, spontaneous bacterial peritonitis